Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-24

Clinical Trial Update: Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

View source ↗

Summary

A real-world data study evaluating the effectiveness of obeticholic acid (Ocaliva) on hepatic outcomes in patients with primary biliary cholangitis has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ocaliva (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Primary Biliary Cholangitis | Status: COMPLETED | Results posted: 2025-01-24